The EFPIA Oncology Platform will today launch its new White Paper, at a high-level policy event in Toledo, Spain, organised in collaboration with Farmaindustria. The paper calls for more coordinated action to reduce persistent disparities in access to targeted cancer treatments and biomarker testing across Europe.
The White Paper, entitled “Advancing precision oncology treatment and testing across Europe: An evidence-based roadmap for healthcare system stakeholders to improve cancer care”, brings together policymakers, clinicians, patient representatives, payers, industry leaders and regional and national health stakeholders to discuss how to translate scientific progress in a more targeted and personalized treatment of cancer into equitable access for patients.
Read the White Paper here.
